(Q54115530)

24 May 2018

title

Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia. (English)

1 reference

24 May 2018

1 reference

1 reference

J L Merlin

1

1 reference

24 May 2018

A P Guerci

2

1 reference

24 May 2018

S Marchal

3

1 reference

24 May 2018

C Bour

4

1 reference

24 May 2018

P Colosetti

5

1 reference

24 May 2018

A Kataki

6

1 reference

24 May 2018

O Guerci

7

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

24 May 2018

British Journal of Haematology

published in

1 reference

24 May 2018

volume

103

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

480-487

1 reference

24 May 2018

Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

Molecular interactions of cyclosporin A with P-glycoprotein. Photolabeling with cyclosporin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

Modulation of daunorubicin intracellular accumulation in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells by thermosensitive-liposome encapsulation and hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01001.X

10.1046/J.1365-2141.1998.01001.X

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

9827923

1 reference

24 May 2018